Nomura Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Nomura Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.8K	Buy	+1,100	New	+$20.8K	﹤0.01%	1317
2021 Q2	–	Sell	-13,430	Closed	-$1.02M	–	984
2021 Q1	$1M	Hold	13,430	–	–	0.01%	832
2020 Q4	$2.29M	Buy	13,430 +1,300	+11%	+$193K	0.02%	658
2020 Q3	$1.7M	Hold	12,130	–	–	0.01%	667
2020 Q2	$1.95M	Sell	12,130 -170	-1%	-$23.1K	0.02%	588
2020 Q1	$1.2M	Hold	12,300	–	–	0.01%	652
2019 Q4	$1.59M	Hold	12,300	–	–	0.01%	694
2019 Q3	$926K	Buy	+12,300	New	+$1.45M	0.01%	781

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nomura Asset Management's SRPT Position: Q2 2026 in Review

Nomura Asset Management opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 1,100 shares worth $19.8K. The stake represents ﹤0.01% of the portfolio and ranks #1317 among its holdings. This is a return to the name: Nomura Asset Management previously reported a position in SRPT as recently as Q1 2021.

Nomura Asset Management first reported a position in SRPT in Q3 2019 and has held it in 8 quarters since. The position peaked at $2.29M in Q4 2020. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Nomura Asset Management held 1,100 shares of Sarepta Therapeutics worth $19.8K as of Q2 2026.
Sarepta Therapeutics was a new Nomura Asset Management position in Q2 2026.
Sarepta Therapeutics made up ﹤0.01% of Nomura Asset Management's portfolio in Q2 2026, its #1317 holding.
Nomura Asset Management first reported a position in Sarepta Therapeutics in Q3 2019 and has held it in 8 quarters since.
Nomura Asset Management's Sarepta Therapeutics position peaked at $2.29M in Q4 2020.
324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.